Dr. Marty Makary
Coverage of Dr. Marty Makary in the Nexus archive.
- Second FDA executive departing organization in less than a week as top drug regulator claims she was fired
Dr. Tracy Beth Høeg, former acting director of the FDA's Center for Drug Evaluation and Research, claimed she was fired, becoming the second high-ranking official to depart the FDA this week. Her departure follows that of former FDA Commissioner Dr. Marty Makary. Høeg will be replaced by her former deputy, Dr. Mike Davis.
- FDA commissioner is set to resign after tumultuous tenure
FDA commissioner Dr. Marty Makary is set to resign after a tumultuous 13-month tenure marked by turmoil and controversy. The resignation will end his stint running the Food and Drug Administration. This period was marked by significant challenges.
- FDA commissioner is set to resign after tumultuous tenure
FDA commissioner Dr. Marty Makary is set to resign after a tumultuous 13-month tenure marked by turmoil and controversy. The resignation will end his stint running the Food and Drug Administration. This period was notable for its challenges and criticisms.
- Dr. Marty Makary out as FDA commissioner
Dr. Marty Makary is out as FDA commissioner due to President Donald Trump's frustration with his performance. The reason for his removal is unclear. Makary's departure was reported by NBC News.
- Dr. Marty Makary is out as FDA commissioner
Dr. Marty Makary is no longer the FDA commissioner. This change may impact the direction of the FDA. The reason for his departure is not specified.
- Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups
Dr. Marty Makary, FDA commissioner, is resigning after a rocky tenure that drew complaints from health industry executives and anti-abortion activists. He struggled to manage the FDA's bureaucracy and failed to win the confidence of its staff. His resignation comes after just over a year leading the agency.